Impact of pulmonary and extrapulmonary tuberculosis infection in kidney transplantation: A nationwide population-based study in Taiwan

Transplant Infectious Disease

Volumn 14, Issue 5, 2012, Pages 502-509

  Ou, S M ^a,b   Liu, C J ^a,c   Teng, C J ^c   Lin, Y T ^a,c   Chang, Y S ^a,c   Chiang, S C ^a,c   Tzeng, C H ^a,c   Chen, T J ^a,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Chronic obstructive pulmonary disease; Extrapulmonary tuberculosis; Hepatitis C; Immunosuppressants; Kidney transplantation; Pulmonary tuberculosis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; EXTRAPULMONARY TUBERCULOSIS; FEMALE; GRAFT RECIPIENT; HEPATITIS C; HIGH RISK PATIENT; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; KIDNEY TRANSPLANTATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MILIARY TUBERCULOSIS; MORBIDITY; OUTCOME ASSESSMENT; POPULATION RESEARCH; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RISK FACTOR; SKIN TUBERCULOSIS; SURVIVAL RATE; TAIWAN; TUBERCULOUS LYMPHADENITIS; TUBERCULOUS PERITONITIS; TUBERCULOUS PLEURISY;

ADULT; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SURVIVAL RATE; TAIWAN; TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 84867641105     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2012.00737.x     Document Type: Article

References (31)

1. Hussein MM, Mooij JM, Roujouleh H. Tuberculosis and chronic renal disease. Semin Dial 2003; 16 (1): 38-44.
2. Jha V, Sakhuja V, Gupta D, et al. Successful management of pulmonary tuberculosis in renal allograft recipients in a single center. Kidney Int 1999; 56 (5): 1944-1950.
3. Ram R, Swarnalatha G, Prasad N, Dakshinamurty KV. Tuberculosis in renal transplant recipients. Transpl Infect Dis 2007; 9 (2): 97-101.
4. Naqvi R, Naqvi A, Akhtar S, et al. Use of isoniazid chemoprophylaxis in renal transplant recipients. Nephrol Dial Transplant 2010; 25 (2): 634-637.
5. Kaaroud H, Beji S, Boubaker K, et al. Tuberculosis after renal transplantation. Transplant Proc 2007; 39 (4): 1012-1013.
6. Rungruanghiranya S, Ekpanyaskul C, Jirasiritum S, Nilthong C, Pipatpanawong K, Mavichak V. Tuberculosis in Thai renal transplant recipients: a 15-year experience. Transplant Proc 2008; 40 (7): 2376-2379.
7. Subramanian AK, Nuermberger EL. Tuberculosis in transplant recipients: diagnostic and therapeutic dilemmas. Transpl Infect Dis 2008; 10 (4): 229-230.
8. Guida JP, Bignotto Rosane D, Urbini-Santos C, Alves-Filho G, Ribeiro Resende M, Mazzali M. Tuberculosis in renal transplant recipients: a Brazilian center registry. Transplant Proc 2009; 41 (3): 883-884.
9. Fishman JA. Infection in renal transplant recipients. Semin Nephrol 2007; 27 (4): 445-461.
10. Yang WC, Hwang SJ. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance. Nephrol Dial Transplant 2008; 23 (12): 3977-3982.
11. John GT, Shankar V, Abraham AM, Mukundan U, Thomas PP, Jacob CK. Risk factors for post-transplant tuberculosis. Kidney Int 2001; 60 (3): 1148-1153.
12. Chen CH, Lian JD, Cheng CH, Wu MJ, Lee WC, Shu KH. Mycobacterium tuberculosis infection following renal transplantation in Taiwan. Transpl Infect Dis 2006; 8 (3): 148-156.
13. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998; 27 (5): 1266-1277.
14. Li SY, Chen TJ, Chung KW, et al. Mycobacterium tuberculosis infection of end-stage renal disease patients in Taiwan: a nationwide longitudinal study. Clin Microbiol Infect 2011; 17 (11): 1646-1652.
15. Zarocostas J. WHO calls for extra resources to step up fight against tuberculosis. BMJ 2008; 336 (7645): 631.
16. Lai CC, Tan CK, Lin SH, et al. Molecular evidence of false-positive cultures for Mycobacterium tuberculosis in a Taiwanese hospital with a high incidence of TB. Chest 2010; 137 (5): 1065-1070.
17. Centers for Disease Control and Prevention. Trends in tuberculosis incidence-United States, 2006. MMWR Morb Mortal Wkly Rep 2007; 56 (11): 245-250.
18. John GT, Date A, Mathew CM, Jeyaseelan L, Jacob CK, Shastry JC. A time table for infections after renal transplantation in the tropics. Transplantation 1996; 61 (6): 970-972.
19. Chen HL, Wu MS, Chang WH, Shih SC, Chi H, Bair MJ. Abdominal tuberculosis in southeastern Taiwan: 20 years of experience. J Formos Med Assoc 2009; 108 (3): 195-201.
20. Yang Z, Kong Y, Wilson F, et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis 2004; 38 (2): 199-205.
21. Krishnan N, Robertson BD, Thwaites G. The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2010; 90 (6): 361-366.
22. Donald PR, Marais BJ, Barry CE 3rd. Age and the epidemiology and pathogenesis of tuberculosis. Lancet 2010; 375 (9729): 1852-1854.
23. Allotey P, Gyapong M. Gender in tuberculosis research. Int J Tuberc Lung Dis 2008; 12 (7): 831-836.
24. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009; 9 (12): 737-746.
25. Inghammar M, Ekbom A, Engstrom G, et al. COPD and the risk of tuberculosis-a population-based cohort study. PLoS ONE 2010; 5 (4): e10138.
26. Antonucci G, Girardi E, Raviglione MC, Ippolito G. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA 1995; 274 (2): 143-148.
27. Toz H, Nart D, Turan I, et al. The acquisition time of infection: a determinant of the severity of hepatitis C virus-related liver disease in renal transplant patients. Clin Transplant 2009; 23 (5): 723-731.
28. Torres J, Aguado JM, San Juan R, et al. Hepatitis C virus, an important risk factor for tuberculosis in immunocompromised: experience with kidney transplantation. Transpl Int 2008; 21 (9): 873-878.
29. Corell A, Morales JM, Mandrono A, et al. Immunosuppression induced by hepatitis C virus infection reduces acute renal-transplant rejection. Lancet 1995; 346 (8988): 1497-1498.
30. John GT, Shankar V. Mycobacterial infections in organ transplant recipients. Semin Respir Infect 2002; 17 (4): 274-283.
31. Sester U, Wilkens H, van Bentum K, et al. Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs. Eur Respir J 2009; 34 (3): 702-710.